Imagin Medical Inc
Company Profile
Business description
Imagin Medical Inc is a surgical imaging company focused on developing technology to visualize cancer during minimally invasive procedures. Its initial focus is bladder cancer. Imagin's first product, the i/Blue Imaging System, is based on optics and light sensors and employs patented ultrasensitive imaging technology. The company believes the system, currently in the manufacturing stage, will significantly improve surgeon's ability to visualize and remove cancer cells. Run by a Boston-based management team, the company will work to enhance its market potential in the future by expanding its technology to multiple endoscopic procedures, such as laparoscopic and thoracic procedures, accommodating multiple contrast agents and illumination sources.
Contact
890 West Pender Street
Suite 600
VancouverBCV6C 1J9
CANT: +1 833 246-2446
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
30 September 2025
Employees
Stocks News & Analysis
stocks
10 of the cheapest global companies with wide moats
stocks
Bookworm: Buy and hold inspiration from an unlikely source
stocks
3 ASX shares to avoid
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,082.10 | 68.80 | 0.86% |
CAC 40 | 8,073.98 | 45.70 | 0.57% |
DAX 40 | 23,154.57 | 167.75 | 0.73% |
Dow JONES (US) | 41,841.63 | 353.44 | 0.85% |
FTSE 100 | 8,680.29 | 47.96 | 0.56% |
HKSE | 24,145.57 | 185.59 | 0.77% |
NASDAQ | 17,808.66 | 54.58 | 0.31% |
Nikkei 225 | 37,396.52 | 343.42 | 0.93% |
NZX 50 Index | 12,154.23 | 11.91 | -0.10% |
S&P 500 | 5,675.12 | 36.18 | 0.64% |
S&P/ASX 200 | 7,854.10 | 64.40 | 0.83% |
SSE Composite Index | 3,426.13 | 6.57 | 0.19% |